Insiders · Profile

ABERNETHY MATT

Chief Financial Officer at NEUROCRINE BIOSCIENCES. Filing since 3 Dec 2018. CIK 0001724097

Company

Date

Role

Action

Shares

Amount

Of holding

NBIX NEUROCRINE BIOSCIENCES INC

14 Sep 2026

Chief Financial Officer

Sold on a plan

2,311

$363.28K

5.1%

NBIX NEUROCRINE BIOSCIENCES INC

13 Feb 2025

Chief Financial Officer

Sold on a plan

2,558

$298.92K

6.9%

NBIX NEUROCRINE BIOSCIENCES INC

10 Feb 2025

Chief Financial Officer

Sold on a plan

980

$115.91K

2.8%

NBIX NEUROCRINE BIOSCIENCES INC

31 Jan 2025

Chief Financial Officer

Sold on a plan

1,283

$196.14K

3.8%

NBIX NEUROCRINE BIOSCIENCES INC

13 Aug 2024

Chief Financial Officer

Sold on a plan

14,100

$2.12M

30.9%

NBIX NEUROCRINE BIOSCIENCES INC

16 Jul 2024

Chief Financial Officer

Sold on a plan

900

$135.04K

2.8%

NBIX NEUROCRINE BIOSCIENCES INC

15 May 2024

Chief Financial Officer

Sold on a plan

15,000

$2.10M

32.2%

NBIX NEUROCRINE BIOSCIENCES INC

14 May 2024

Chief Financial Officer

Sold on a plan

15,000

$2.03M

32.2%

NBIX NEUROCRINE BIOSCIENCES INC

13 Feb 2024

Chief Financial Officer

Sold on a plan

1,352

$179.61K

4.1%

NBIX NEUROCRINE BIOSCIENCES INC

8 Feb 2024

Chief Financial Officer

Sold on a plan

980

$131.53K

3.1%

NBIX NEUROCRINE BIOSCIENCES INC

6 Feb 2024

Chief Financial Officer

Sold on a plan

1,280

$182.00K

4.2%

NBIX NEUROCRINE BIOSCIENCES INC

31 Jan 2024

Chief Financial Officer

Sold on a plan

1,283

$180.54K

4.3%

NBIX NEUROCRINE BIOSCIENCES INC

21 Aug 2023

Chief Financial Officer

Sold on a plan

2,132

$228.96K

7.3%

NBIX NEUROCRINE BIOSCIENCES INC

8 Feb 2023

Chief Financial Officer

Sold, plan not stated

980

$102.11K

3.7%

NBIX NEUROCRINE BIOSCIENCES INC

7 Feb 2023

Chief Financial Officer

Sold, plan not stated

26,328

$2.70M

52.0%

NBIX NEUROCRINE BIOSCIENCES INC

6 Feb 2023

Chief Financial Officer

Sold, plan not stated

1,280

$135.25K

5.4%

NBIX NEUROCRINE BIOSCIENCES INC

31 Jan 2023

Chief Financial Officer

Sold, plan not stated

1,283

$141.11K

5.7%

NBIX NEUROCRINE BIOSCIENCES INC

8 Feb 2022

Chief Financial Officer

Sold, plan not stated

980

$78.06K

4.6%

NBIX NEUROCRINE BIOSCIENCES INC

7 Feb 2022

Chief Financial Officer

Sold, plan not stated

3,310

$267.43K

15.4%

NBIX NEUROCRINE BIOSCIENCES INC

1 Dec 2021

Chief Financial Officer

Sold, plan not stated

1,645

$135.85K

9.1%

NBIX NEUROCRINE BIOSCIENCES INC

8 Feb 2021

Chief Financial Officer

Sold, plan not stated

2,910

$339.94K

18.2%

NBIX NEUROCRINE BIOSCIENCES INC

1 Dec 2020

Chief Financial Officer

Sold, plan not stated

1,645

$155.72K

12.5%

NBIX NEUROCRINE BIOSCIENCES INC

12 Nov 2020

Chief Financial Officer

Sold, plan not stated

2,257

$204.81K

18.4%

NBIX NEUROCRINE BIOSCIENCES INC

5 Aug 2020

Chief Financial Officer

Sold, plan not stated

2,257

$268.36K

22.0%

NBIX NEUROCRINE BIOSCIENCES INC

7 May 2020

Chief Financial Officer

Sold, plan not stated

15,000

$1.65M

71.6%

NBIX NEUROCRINE BIOSCIENCES INC

28 Apr 2020

Chief Financial Officer

Sold, plan not stated

1,741

$178.44K

22.6%

NBIX NEUROCRINE BIOSCIENCES INC

24 Apr 2020

Chief Financial Officer

Sold, plan not stated

1,934

$192.47K

20.1%

NBIX NEUROCRINE BIOSCIENCES INC

7 Feb 2020

Chief Financial Officer

Sold, plan not stated

2,030

$209.81K

26.3%

NBIX NEUROCRINE BIOSCIENCES INC

2 Dec 2019

Chief Financial Officer

Sold, plan not stated

1,645

$191.36K

29.8%

NBIX NEUROCRINE BIOSCIENCES INC

3 Dec 2018

Chief Financial Officer

Sold, plan not stated

1,178

$106.02K

37.7%

30 decisions on file.